ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...
DUBLIN--(BUSINESS WIRE)--The "Atherectomy Devices Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis" report has been ...
New York, Nov. 26, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Spain Atherectomy Devices Market Outlook to 2025 - Coronary Atherectomy Devices and Lower Extremity ...
Dublin, Jan. 16, 2026 (GLOBE NEWSWIRE) -- The "Atherectomy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036" report has been added to ...
The proliferation of outpatient and ambulatory surgical centers has further enhanced the accessibility of atherectomy procedures, creating a favorable environment for market expansion. Despite this ...
Cardiovascular Systems, Inc. CSII recently released results from a real-world optical coherence tomography (OCT) imaging study at EuroPCR 2021 of Coronary Orbital Atherectomy System (OAS) patients.
Please provide your email address to receive an email when new articles are posted on . Orbital atherectomy was no better than balloon angioplasty for treatment of certain severely calcified coronary ...
Routine use of an orbital atherectomy device to remove calcium from severely blocked coronary arteries before patients undergo cardiac stenting procedures does not improve outcomes, a Mount Sinai-led ...
Introduction of Orbital Atherectomy in Canada Expands Treatment Options for Patients with Complex Coronary Artery Disease Dr. Kalra said, “Patients with calcific coronary artery disease can have poor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results